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Background: Vitamin D is well recognized for its role in skeletal health and its involvement in the modulation of
the immune system. In the literature, controversial results are reported for atopic diseases. Thus, we investigated the
association between vitamin D status and the prevalence of atopic diseases.
Methods: Serum 25-hydroxy-vitamin D (25(OH)D) concentrations were measured in a sample of 2815 10-years old
children from two German birth cohort studies. Self-reported physician-diagnosed eczema, hay fever or allergic rhinitis,
and asthma were used as outcome variables as well as specific IgE positivity against common allergens. We applied
logistic regression models, deriving adjusted odds ratio estimates (aOR) and 95% confidence intervals (CI).
Results: For asthma and hay fever or allergic rhinitis, no associations existed with serum 25(OH)D concentrations.
We observed a significant positive relationship between serum 25(OH)D levels and eczema at age 10 (aOR = 1.09,
CI = 1.01-1.17, per 10 nmol/l increase in serum 25(OH)D levels) and for the lifetime prevalence of eczema
(aOR = 1.05, CI = 1.01-1.09). Specific IgE positivity for food allergens (aOR = 1.07, CI = 1.02-1.11) and aeroallergens
(aOR = 1.05, CI = 1.01-1.08) at age 10, as well as lifetime prevalence, was significantly related to the vitamin D status.
Conclusion: In this study we found no indication that higher blood 25(OH)D levels are associated with decreased
risk for any of the atopic outcomes in children. However, we observed a positive association of serum 25(OH)D
concentrations with eczema and detectable specific IgE. Due to the given limitations of our study, the clinical
relevance of these findings needs further clarification.
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The increasing prevalence of atopic diseases during past
decades in many countries led to a large number of
studies, establishing life style and environmental factors
as risk factors, as well as a genetic predisposition [1].
The biologically most active vitamin D metabolite 1,25
(OH)2 vitamin D (calcitriol) is known to affect immune
and airway functions, which is the basis of the hypoth-
esis that vitamin D status may be directly linked to
asthma and allergic diseases [2,3]. Meanwhile, several* Correspondence: j.linseisen@helmholtz-muenchen.de
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unless otherwise stated.reviews have been published summarizing the existing
evidence on vitamin D and atopic diseases or asthma
[4-9]. The reviews highlight the lack of consistent evidence
for a causal protective association between vitamin D
(i.e. plasma levels as well as supplementary dietary intake)
and atopic diseases.
A unique characteristic of vitamin D is that it is mostly
produced by the human body after the skin is exposed to
sunlight (UVB). Actually, the contribution of vitamin D
intake from habitual diet to the overall vitamin D supply is
limited, while endogenous synthesis is estimated to con-
tribute up to 90% of the bodies’ vitamin D (e.g. [10]). The
serum concentration of 25-hydroxy-vitamin D (25(OH)D)
is an established biomarker for determining vitamin D
status (see e.g. [11]).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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indoors and consequently the exposure to sunlight is
reduced, leading to vitamin D insufficiency and, given a
causal relationship, to more cases of asthma and allergy.
Prenatal deficiency of vitamin D may already affect the
development of the fetal lung and immune system which
could be worsened by a postnatal deficiency of vitamin D
[12]. This hypothesis of an association between vitamin D
deficiency and higher rates of atopic diseases and allergic
sensitization is supported by numerous studies [13-16].
In contrast, Wjst & Hyppönen see a positive association
of vitamin D with allergic rhinitis in adults, which may
be explained by subtle differences in the vitamin D metab-
olism or sensitivity in allergic patients [17]. This contro-
versial speculation was recently supported by increased
risk for food allergy within the first two years in children
with high vitamin D levels in cord blood [18] and a signifi-
cant inverse association of low serum vitamin D level with
eczema prevalence [19]. In this situation, our study aims
to contribute to this field of strong scientific interest by
analyzing the relationship of serum vitamin D status at the
age of ten and the prevalence of atopic diseases at the
same age or life-time prevalence of these diseases.
Methods
Study population
The analysis was based on samples from two German birth
cohort studies, namely the German Infant Study on the
Influence of Nutrition Intervention plus Air pollution and
Genetics on Allergy Development (GINIplus) study and
the Influence of Life-style factors on Development of the
Immune System and Allergies in East and West Germany
plus Air Pollution and Genetics on Allergy Development
(LISAplus) study, that were recruited from 1995 to 1998 in
Munich and Wesel, and from 1997 to 1999 in Munich,
Wesel, Bad Honnef and Leipzig, respectively.
Briefly, participants were recruited in maternity wards,
and parents were invited to fill in self-administered ques-
tionnaires. Since then, families were regularly contacted,
and information on disease outcomes in the children was
collected by questionnaires and medical examinations.
Within the GINIplus framework, children were allocated
to either an interventional study arm or an observational
study arm, based on parental history of allergic diseases
and consent for intervention. GINI aimed to investigate
the allergy-preventive effect of 3 differently hydrolyzed
infant formulas compared with a conventional cow’s milk
formula in infants at risk for atopy in a randomized and
double-blind design. During the strict intervention period
of four month, mothers were encouraged to exclusively
breast-feed and asked to do this preferably for 6 months.
It was left to the mother to introduce the study formula,
which was provided until the participating child was
6 months old. Mothers were asked to feed no solidfoods during the first four months and weekly diaries were
filled out documenting the kind of milk the child was fed.
In the LISAplus study children were not preselected on
parental history of allergic diseases. The LISA study aimed
to investigate immunoglobulin E (IgE)-dependent allergic
symptoms or diseases in the first 2 years of life as well as
to determine parameters of the immune system’s matur-
ation and activation. Both studies were approved by the
local ethical committees (Bavarian Board of Physicians,
University of Leipzig, Board of Physicians of North-Rhine-
Westphalia), and families gave their informed consent
prior to their inclusion in the study.
In the first wave about 6000 newborns were recruited
within the GINI study and about 3100 newborns within
the LISA study. We analyzed data of 2815 children who
participated in the 10 year follow-up and for which at
least data on serum 25(OH)D concentration was available.
The following data from the 10-year follow-up question-
naire and medical examination was used: measured weight
and height, single-parent status, and net equivalent in-
come. The 10-year follow-up medical examinations took
place from April 2005 to December 2009. Detailed descrip-
tions of both studies were published elsewhere [20,21].
When examining the distributions of the covariates
from those participating in the questionnaire at age 1 year
and in the assessment at age 10 years (questionnaire and
the corresponding medical examination, serum vitamin D),
we found only slight changes (see Additional file 1). Solely
for the distribution of ‘study’ we found a higher loss of
follow-up in the observational arm of GINIplus.
Outcome assessment
We investigated different atopic diseases, either diag-
nosed at the age of 10 years, or ever diagnosed since
birth. All these outcomes are assessed on the basis of
self-administered questionnaires data. For asthma, ec-
zema and hay fever or rhinitis, participants were catego-
rized as ‘cases’ at the age of 10 years if a physician first
diagnosed or confirmed the diagnosis of the disease dur-
ing the last 12 month before the 10 year questionnaire
was filled in, thereby not taking into account any infor-
mation on allergic sensitization. For the definition of ‘ever’
diagnosis of these diseases information from all question-
naires from birth up to the 10 year follow-up was used
(self-reports of physician diagnosed diseases). If at least at
one time point a disease was reported the participating
child was treated as a case for that outcome.
For definition of allergic sensitization, the serum con-
centrations of specific IgE antibodies against common
inhalant (SX1) or food allergens (FX5) at the age of 6
and 10 years were measured. Children with specific IgE
values higher than 0.35 kU/l were regarded as sensitized
(Pharmacia CAP System (Pharmacia Diagnostics, Freiburg,
Germany). For the definition of ‘ever’ sensitization, at least
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and 10, must have been positive.
For all outcomes regarding the ‘ever diagnosis’, to
minimize the number of missing observations, the status
‘missing’ was only assigned when all relevant answers to
determine the status were missing. In return, this means
that the status ‘non-diseased control’ was assigned even
when one or more answers were missing, as long as no
diagnosis by a physician was affirmed.
Determination of serum 25(OH)D concentration
Blood samples were collected at age of 10 years during
the clinical examination, centrifuged after collection, and
stored frozen at –80° until assayed for vitamin D. Only
one measurement per sample was conducted.
Total serum 25(OH)D concentration was determined by
Roche Vitamin D total on the fully automated Modular
system (E170, Roche Diagnostics, Mannheim, Germany).
The specificity is reported by the manufacturer as 25
(OH)D2 = 81%; 25(OH)D3 = 98%; 1,25(OH)2D2 = 6%; 1,25
(OH)2D3 = 5%; 24,25(OH)2 = 121%, and the lower limit of
detection as 3 ng/mL. The intra-assay CV is 2.2-6.8% for
sera with levels between 8.35 - 69.6 ng/mL, the inter-assay
CV as provided by the manufacturer is 3.4-13.1% for levels
between 8.35-69.6 ng/mL.
Statistical analysis
All analyses were conducted using SAS for Windows,
version 9.2 (SAS Institute, Cary, N.C., USA).
It is well known, that the vitamin D status which is
assessed best by serum 25(OH)D concentration, strongly
depends on sunlight (UVB) exposure which induces the
endogenous production of vitamin D in the skin. There-
fore, we adjusted the serum 25(OH)D values for date of
blood collection by fitting a non-parametric LOESS re-
gression. Our LOESS regression explained the observed
serum 25(OH)D value by the date of blood collection.
Season-adjusted serum 25(OH)D values were computed
by adding the overall mean to the residuals derived from
the LOESS regression. The rationale behind this is that
the residuals represent the remaining variation of the
serum values, whereas the seasonal effect was accounted
for by the date of blood collection. Adding the residuals
to the overall mean of the serum values yields a well
interpretable adjusted variable. These season-adjusted
serum 25(OH)D values were introduced as continuous
variable in the logistic regression models, or classified in
quartiles based on the distribution of the entire cohort,
where the first quartile served as reference category.
To assess the association between serum 25(OH)D levels
and the atopic disease status we fitted logistic regression
models. Minimally adjusted odds ratio estimates were ob-
tained by adjustment for age (continuous), sex, study
(GINI observational arm/GINIinterventional arm/LISA),and study location (Munich/Wesel/Bad Honnef/Leipzig).
The fully adjusted logistic regression models further in-
cluded the following variables: breastfeeding (exclusively
breastfed/breast and formula fed/exclusively formula fed)
during the first four months, child’s BMI (continuous),
parental education (categorized as low/medium/high
based on the highest number of school years being lower,
equal or higher than 10 years), single parent status
(yes/no), and parental history of atopic diseases (none/one/
both parents).
Whenever the variable sex was identified as an effect
modifier, e.g. the interaction term between sex and con-
tinuous 25(OH)D serum level was significantly associ-
ated with the outcome (p < 0.05), a stratified analysis was
performed.
Additionally, we fitted three models comparing those
that never suffered from eczema versus those who suf-
fered transiently and those who suffered persistently.
We ran sensitivity analysis examining higher cut-points
for the specific IgEs, considering net equivalent income
and by performing a complete case analysis to examine a
possible influence of missing observations on the definition
of the control status of the clinical outcomes.
A sub-analysis was carried out within the framework
of the LISAplus study, using the monthly status on vita-
min D supplementation available during the first year of
life. We extended the models described above by includ-
ing the main effect of length of supplementation and an
interaction term thereof and 25(OH)D serum level. We
investigated categories of at least 4, 6 or 12 months of
supplementation, respectively.
Results
Descriptive statistics on the 2815 children included in
this analysis are shown in the Table 1. Tables 2, 3 and 4
show the results of the fully adjusted models fitted for
all clinical and non-clinical outcomes. Results from min-
imally adjusted models differed only slightly (data not
shown). Based on the continuous 25(OH)D variable [per
10 nmol/l] and the adjusted models, vitamin D status
was significantly positively associated with the preva-
lence of eczema at age 10 (aOR = 1.09, CI = 1.01-1.17 per
10nmol/l) as well as with the lifetime prevalence of
eczema (aOR = 1.05; CI = 1.01-1.09 per 10 nmol/l). The
results of the categorized variable are given in Figure 1.
Neither for hay fever, nor for allergic rhinitis an associ-
ation with vitamin D status was found. For the con-
densed outcome ‘hay fever or rhinitis’, no association
between disease prevalence and serum 25(OH)D con-
centration was observed, neither at the age of 10 nor for
the lifetime prevalence.
For asthma, no association with vitamin D status was
observed. Due to low numbers, neither the study loca-
tion nor the single-parent status could be taken into
Table 1 Descriptive statistics of the study sample for selected covariates, total and by sex
Total Boys Girls
n (%) n (%) n (%)
Sex Boys 1441 (51.2)
Girls 1374 (48.8)
Study GINIplus observation 835 (29.7) 411 (28.5) 424 (30.9)
GINIplus intervention 923 (32.8) 463 (32.1) 460 (33.5)
LISAplus 1057 (37.6) 567 (39.4) 490 (35.7)
Study location Munich 1553 (55.2) 799 (55.5) 754 (54.9)
Wesel 836 (29.7) 417 (28.9) 419 (30.5)
Bad Honnef 148 (5.3) 76 (5.3) 72 (5.2)
Leipzig 278 (9.9) 149 (10.3) 129 (9.4)
Parental education Low 160 (5.9) 86 (6.2) 74 (5.6)
Medium 706 (26.0) 364 (26.3) 342 (25.7)
High 1850 (68.1) 936 (67.5) 914 (68.7)
Single parent family Yes 328 (11.8) 167 (11.8) 161 (11.9)
No 2443 (88.2) 1254 (88.3) 1189 (88.1)
Parental history of atopic diseases 0 1106 (42.7) 563 (42.8) 543 (42.7)
1 1124 (43.4) 575 (43.7) 549 (43.2)
2 358 (13.8) 179 (13.6) 179 (14.1)
mean (sd) mean (sd) mean (sd)
Age 10.2 (0.4) 10.2 (0.4) 10.2 (0.4)
BMI 17.4 (2.5) 17.4 (2.5) 17.4 (2.5)
Season adjusted vitamin D [nmol/l] 74.2 (23.3) 75.2 (23.8) 73.1 (22.8)
1. quartile 2. quartile 3. quartile 4. quartile
Season adjusted Vitamin D [nmol/l] <57.9 57.9- <71.5 71.5- <87.8 87.8 or higher
Table 2 Odds ratio estimates and 95% confidence intervals for the association of vitamin D status and atopic diseases
diagnosed at the age of 10 years
Outcome: at the age of 10 years
Outcome OR (CI)
1. Quartile 2. Quartile 3. Quartile 4. Quartile Continuous [per 10 nmol/l]
Asthma male Cases/Non-diseased (% Cases) 21/271 (7%) 16/309 (5%) 14/282 (5%) 15/312 (5%) 66/1174 (5%)
Adjusted model1 1 0.59 (0.30;1.16) 0.57 (0.28;1.17) 0.58 (0.29;1.17) 0.92 (0.82;1.03)
Asthma female Cases/Non-diseased (% Cases) 4/301 (1%) 8/290 (3%) 8/285 (3%) 9/280 (3%) 29/1156 (2%)
Adjusted model1 1 2.20 (0.66;7.50) 2.07 (0.61;7.05) 2.58 (0.76;8.57) 1.12 (0.97;1.30)
Eczema Cases/Non-diseased (% Cases) 18/569 (3%) 36/567 (6%) 38/536 (7%) 31/580 (5%) 123/2252 (5%)
Adjusted model2 1 2.01* (1.12;3.60) 2.27* (1.27;4.06) 1.82 (1.00;3.31) 1.09* (1.01;1.17)
Hay fever or allergic
rhinitis
Cases/Non-diseased (% Cases) 57/536 (10%) 77/539 (13%) 66/513 (11%) 67/548 (11%) 267/2136 (11%)
Adjusted model2 1 1.28 (0.89;1.86) 1.12 (0.76;1.64) 1.07 (0.73;1.57) 0.98 (0.93;1.04)
1Outcome = Vitamin D concentration + age + study + breastfeeding + BMI + highest parental education + family history.
2Outcome = Vitamin D concentration + age + sex + location of study + study + breastfeeding + BMI + highest parental education + single parent
status + family history.
The OR estimates and 95% CI for the association of vitamin D status (serum 25(OH)D concentration in quartiles or as continuous variable [10 nmol/l]) and atopic
diseases diagnosed at the age of 10 years are displayed. The asterisk indicate significant results at p < 0.05.
Wawro et al. BMC Pediatrics 2014, 14:286 Page 4 of 9
http://www.biomedcentral.com/1471-2431/14/286




1. Quartile 2. Quartile 3. Quartile 4. Quartile Continuous [per 10 nmol/l]
Asthma male Cases/Non-diseased (% Cases) 34/265 (11%) 35/297 (11%) 25/282 (8%) 39/303 (11%) 133/1147 (10%)
Adjusted model1 1 0.84 (0.50;1.40) 0.65 (0.37;1.13) 0.97 (0.59;1.61) 1.00 (0.92;1.07)
Asthma female Cases/Non-diseased (% Cases) 15/295 (5%) 22/281 (7%) 22/289 (7%) 17/278 (6%) 76/1143 (6%)
Adjusted model1 1 1.54 (0.78;3.06) 1.48 (0.74;2.93) 1.21 (0.59;2.50) 1.02 (0.92;1.13)
Eczema Cases/Non-diseased (% Cases) 173/430 (29%) 196/430 (31%) 184/420 (30%) 195/433 (31%) 748/1713 (30%)
Adjusted model2 1 1.12 (0.87;1.44) 1.09 (0.84;1.40) 1.14 (0.89;1.46) 1.05* (1.01;1.09)
Hay fever or allergic
rhinitis
Cases/Non-diseased (% Cases) 99/504 (16%) 119/507 (19%) 117/487 (19%) 121/507 (19%) 456/2005 (19%)
Adjusted model2 1 1.13 (0.84;1.53) 1.16 (0.86;1.57) 1.15 (0.85;1.56) 1.02 (0.98;1.07)
1Outcome = Vitamin D concentration + age + study + breastfeeding + BMI + highest parental education + family history.
2Outcome = Vitamin D concentration + age + sex + location of study + study + breastfeeding + BMI + highest parental education + single parent status + family history.
The OR estimates and 95% CI for the association of vitamin D status (serum 25(OH)D concentration in quartiles or as continuous variable [10 nmol/l]) and ever
diagnosed atopic diseases are displayed. The asterisk indicate significant results at p < 0.05.
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nor in girls vitamin D status and asthma were signifi-
cantly associated.
Regarding allergic sensitization (Table 4), significant
associations exist between vitamin D status and specific
IgE against food allergens (aOR = 1.07; CI = 1.02-1.11
at the age of 10, aOR = 1.06; CI = 1.02-1.11 for ever
sensitization). A similar result was observed for serumTable 4 Odds ratios and 95% confidence intervals for the ass
the age of 10 years and ever sensitization
Outcome Outcome: at the a
OR (CI)
1. Quartile 2. Q
Spec. IgE (food allergen mixture) Cases/Non-diseased
(% Cases)
100/503 (17%) 98/5
Adjusted model1 1 0.91
Spec. IgE (inhalant allergen mixture) Cases/Non-diseased
(% Cases)
220/383 (36%) 244/
Adjusted model1 1 1.08
Outcome Outcome: ever dia
OR (CI)
1. Quartile 2. Q
Spec. IgE (food allergen mixture) Cases/Non-diseased
(% Cases)
121/351 (26%) 118/
Adjusted model1 1 0.92
Spec. IgE (inhalant allergen mixture) Cases/Non-diseased
(% Cases)
229/270 (46%) 250/
Adjusted model1 1 1.06
1Outcome = Vitamin D concentration + age + sex + location of study + study + breastfeed
The OR estimates and 95% CI for the association of vitamin D status (serum 25(OH)
sensitization (specific serum IgE concentrations) at the age of 10 years and ever sen
6 years and 10 years). The asterisk indicate significant results at p < 0.05.concentrations of specific IgE against inhalant allergens:
the adjusted OR was 1.05 (CI = 1.01-1.08) at the age
of 10 years and aOR = 1.05 (CI = 1.01-1.10) for ever
sensitization.
Table 5 shows the results from the additional analysis
of eczema. A significant association of vitamin D status
at the age of 10 and prevalence of eczema was confirmed
by the results of the continuous 25OHD variable onlyociation of vitamin D status and allergic sensitization at
ge of 10 years
uartile 3. Quartile 4. Quartile Continuous [per 10 nmol/l]
28 (16%) 123/481 (20%) 130/498 (21%) 451/2010 (18%)
(0.67;1.25) 1.25 (0.93;1.69) 1.30 (0.97;1.75) 1.07* (1.02;1.11)
382 (39%) 238/366 (39%) 268/360 (43%) 970/1491 (39%)
(0.85;1.36) 1.09 (0.86;1.38) 1.24 (0.98;1.57) 1.05* (1.01;1.08)
gnosis
uartile 3. Quartile 4. Quartile Continuous [per 10 nmol/l]
377 (24%) 137/352 (28%) 157/346 (31%) 533/1426 (27%)
(0.68;1.23) 1.13 (0.84;1.51) 1.33 (1.00;1.77) 1.06* (1.02;1.11)
275 (48%) 243/276 (47%) 281/239 (54%) 1003/1060 (49%)
(0.83;1.37) 1.02 (0.79;1.32) 1.34* (1.04;1.73) 1.05* (1.01;1.10)
ing + BMI + highest parental education + single parent status + family history.
D concentration in quartiles or as continuous variable [10 nmol/l]) and allergic
sitization (specific serum IgE concentrations that were measured at the age of
Figure 1 OR estimates and 95% CI for the association of vitamin D status and eczema diagnosed at age 10 years. OR estimates and 95% CI
for the association of vitamin D status categorized in quartiles and eczema diagnosed at age 10 years. First quartile served as reference category.
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dren’ (aOR = 1.09; CI = 1.03-1.16). In both other settings
(i.e., early or late transient cases), no significant associa-
tions existed.
Considering additionally the net equivalent income, no
substantial changes regarding associations of the vitamin
D status and the outcomes were observed, even though
the sample sizes were reduced. When rising the cut-
point of the specific IgE serum concentration values
from >0.35 kU/l to >0.7 kU/l for models at age 10, theTable 5 Odds ratio estimates and 95% confidence intervals fo
stratified by age of onset and duration of eczema
OR (CI)
1. Quartile 2. Qua





Adjusted model1 1 1.06 (0





Adjusted model1 1 1.28 (0
Never vs. persistent cases Cases/Non diseased
(% Cases)
52/430 (11%) 64/430
Adjusted model1 1 1.16 (0
1Outcome = Vitamin D concentration + age + sex + location of study + study + breastfeed
The OR estimates and 95% CI for the association of vitamin D status (serum 25(OH)
duration of eczema (never versus early onset but transient, late onset but transient
at p < 0.05.observed risk estimates did not change materially. How-
ever, the association of specific IgE against inhalant aller-
gens and 25(OH)D level dropped below significance
level (results not shown).
The sub-analysis considering vitamin D supplementation
revealed no effect modification by vitamin D supplementa-
tion during the first year of life: neither the main effect
nor the interaction term became significant (results not
shown). This holds for all outcomes examined, but con-
founding by socio-economic factors cannot be ruled out.r the association of vitamin D status and eczema,
rtile 3. Quartile 4. Quartile Continuous [per 10 nmol/l]
0 (20%) 91/420 (18%) 104/433 (19%) 404/1713 (19%)
.78;1.44) 0.93 (0.68;1.28) 1.04 (0.76;1.43) 1.02 (0.97;1.07)
(5%) 32/420 (7%) 20/433 (4%) 96/1713 (5%)
.69;2.39) 1.70 (0.94;3.08) 1.08 (0.56;2.08) 1.04 (0.94;1.14)
(13%) 61/420 (13%) 70/433 (14%) 247/1713 (13%)
.78;1.722) 1.16 (0.78;1.74) 1.36 (0.92;2.01) 1.09* (1.03;1.16)
ing + BMI + highest parental education + single parent status + family history.
D concentration [10 nmol/l]) and eczema, stratified by age of onset and
and persistent cases) are displayed. The asterisk indicate significant results
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We investigated associations of 25(OH)D serum levels at
the age of 10 and prevalence of asthma, eczema, hay fever
or allergic rhinitis, and allergic sensitization. Disease status
at age 10 and lifetime prevalence of disease were analyzed
as outcomes. We observed small but statistically significant
associations of serum 25(OH)D levels and prevalence of
eczema as well as the prevalence of allergic sensitization
against common food and inhalant allergens.
Published findings regarding an association of vitamin D
status and atopic outcomes are not consistent. A com-
parison of the results to our findings is complicated
by differences in the assessment of vitamin D status
(e.g. measurements in cord blood or assessment of mater-
nal vitamin D status during pregnancy), in study designs,
the age of participants or the definition of the outcomes.
For our finding of a slightly increased prevalence for
eczema with high serum 25(OH)D concentrations, only
one directly comparable result could be identified that
was as well derived in a population based cohort of chil-
dren and included serum 25(OH)D concentration meas-
urement. This study also found a decreased prevalence
of atopic eczema with low serum 25(OH)D concentra-
tions in children aged 0-17 years [19]. Also, a positive
association between vitamin D intake and atopic mani-
festations was described [22]. In a study using cord
blood vitamin D levels, no relationship with atopic
eczema in children was found [18], but opposing results
were reported by others [15,16]. The link of the severity
of atopic dermatitis and vitamin D has been confirmed
repeatedly (see e.g. [23] or more recently [24]). Benson
et al. suggested that the inconsistent connection between
vitamin D and allergic skin diseases may be due to a bi-
modal or gender-specific association [25]; this is not
supported by our results.
We could not confirm any association of serum
25(OH)D concentration and hay fever or allergic rhinitis.
Published studies with direct assessment of serum
25(OH)D concentration reported similar null findings
(e.g. in a birth cohort [26]), but as well an increased
prevalence of allergic rhinitis across quartiles of 25(OH)D
concentrations [17]. Furthermore a marginally significant
increase of allergic rhinitis prevalence in the group with
highest vitamin D cord blood was reported [27].
Studies assessing vitamin D status of the mothers or
performing measurements in cord blood samples are
inconclusive regarding the existence of an association
between vitamin D status and risk of asthma [28-30].
Significant associations of asthma and vitamin D have
been reported by other studies that directly measured
serum 25(OH)D concentrations, although the direction
of the associations remains inconclusive. For example,
associations that change direction with increasing age,
from positive to inverse, between serum 25(OH)D levelsand prevalence of asthma were reported [31]. Signifi-
cantly lower serum 25(OH)D levels among the asthmatic
cases in a case-control study conducted in Qatar in chil-
dren [32] and an inverse association of serum 25(OH)D
concentrations and asthma in children [33] have been
published. Low serum 25(OH)D levels at age 6 were
reported as significant predictors for asthma-associated
phenotypes at age 14 in a birth cohort [26]. Recently, an
increased odds of asthma has been reported for low
vitamin D levels in children with atopy [34]. Our results
show no such association.
Regarding allergic sensitization, we reported a signifi-
cant positive association of serum 25(OH)D concentra-
tions and specific IgE against common food allergens
and against inhalant allergens, respectively. Published
results based on direct assessment of serum 25(OH)D
concentrations were either supportive of our findings,
e.g. [26,35] or are contradictory (e.g. [36]). However, results
based on cord blood 25(OH)D concentrations were
contradictory [18,27,37]. In Asian children aged 5-18 years,
no association of serum 25(OH)D status with asthma,
rhinitis, eczema, atopy or total serum IgE was found [38].
Strength and limitations
Measurement of vitamin D status is challenging as
results vary strongly with the methods applied [39]. The
25(OH)D levels analyzed in serum samples of children
participating in the GINIplus and LISAplus study are
considerably higher than reported elsewhere for this age
group. This might be due to the assay applied with a
comparably low specificity for 25(OH)D and a high
cross-reactivity (see Methods section). We used the
serum concentration for ranking (in quartiles) and as a
continuous variable (p trend). However, we avoided inter-
pretation of serum concentrations in terms of sufficiency
of vitamin D supply that requires the application of cut-
off values.
Our evaluation is based on serum 25(OH)D concen-
trations measured in serum samples obtained at one
time point, about 10 years after birth. With the applied
LOESS regression we controlled adequately on a con-
tinuous scale for the seasonal variation in vitamin D sta-
tus; in other studies often only the date or season of
blood collection was included as a confounder in the
analysis. All relevant potential confounders were included
in the adjusted models.
The cross-sectional analysis at age 10 is suitable to
investigate the association of vitamin D status and atopic
diseases. Although the occurrence of atopic diseases from
birth up to age 10 years (‘ever diagnosis’) was included in
our evaluation, serum 25(OH)D concentrations were ana-
lyzed in serum samples obtained at age 10 years. Thus,
reverse causation effects cannot be ruled out (see e.g. [7]).
There is little known about the stability of vitamin D levels
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that the lifetime prevalence of eczema as estimated at the
age of 10 years represents predominantly the persistent
cases of eczema.
Our analysis of clinical endpoints is based on self-
reported physician-based diagnoses and therefore at risk
of reporting bias. Furthermore eczema, allergic rhinitis,
and asthma are each inexact, clinical diagnoses which
might amplify this imprecision. The definition of the
‘non-diseased controls’ as described in the Methods
section is debatable. Among the ‘non-diseased controls’
may be cases who missed to report a physician diagno-
sis. The sensitivity analysis performed included only
complete cases in the definition of the control status.
This led to a remarkably reduced number of controls.
However, no substantial changes regarding the direction
of the OR estimates were observed, supporting the valid-
ity of the approach taken. We included a non-responder
analysis showing that a selective lost for follow up be-
tween the study population and the recruited newborns
is limited.Conclusion
Our main findings are a lack of inverse association be-
tween serum 25(OH)D concentrations and clinically di-
agnosed atopic diseases, but a positive association with
the prevalence of eczema. The associations were signifi-
cant for the categorical and continuous variables of
vitamin D and eczema. However, we see no dose-response
effect. For allergic sensitization we noted a small but sta-
tistically significant association. Even though this associ-
ation has limited clinical relevance, it gives hint on a
specific role of vitamin D on pathophysiologically import-
ant pathways, especially on the regulation of innate and
adaptive immune system as shown in experimental studies
(e.g. [40]). Due to the study design, the results have to be
interpreted carefully. Especially, we cannot rule out the
possibility of reverse causality.Additional file
Additional file 1: Non-responder Analysis. We provide a non-responder
analysis, showing the distribution of relevant covariates at different time
points. Further covariates included in the analysis (BMI, age, net equivalent
income, single parent status) refer to the recording at age 10 not at baseline
and are therefore not included in the table.
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